Neumora Therapeutics (NMRA) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Neumora Therapeutics Inc Put Volume Heavy and Directionally Bearish
TipRanksDec 20 15:35 ET
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
Seeking AlphaDec 20 15:00 ET
Neumora Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Dow JonesDec 16 07:25 ET · Ratings
Express News | Watching Neumora Therapeutics; Shares See Volume To The Upside, Traders Circulate Unconfirmed Analyst Comments Saying "We Remain Buyers Into NMRA's MDD Data, Citing JNJ's Early Completion Of Phase III Aticaprant Study Efficacy And Safety Profile,...
BenzingaDec 6 14:38 ET
J&J Trial News May Have Positive Read for Neumora Therapeutics, Says RBC Capital
TipRanksDec 6 14:30 ET
10 Health Care Stocks With Whale Alerts In Today's Session
BenzingaDec 2 12:35 ET

Comments

Kevin Travers

Oct 21 15:18

Columns Nvidia and Apple Pull Nasdaq Higher with Records, Market Falls | Wall Street Today

The market fell Monday, but $NVIDIA (NVDA.US)$ and $Apple (AAPL.US)$ hit all-time highs. Investors will see some heavy hitter earnings this week, including Tesla on Wednesday, where investors will judge the EV firm's Q3 results.
Just after 4 pm, the $S&P 500 Index (.SPX.US)$ fell 18 basis points, the $Dow Inc (DOW.US)$ fell 0.80%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.27% on tech positivity.
MACRO
This...

Will Nvidia dethrone Apple as world's most valuable company?

54

17

12

Kevin Travers

Oct 21 11:09

Columns Monday Market Pulls Back From Highs, With Earnings To Come | Moovin Stonks

Good afternoon traders, happy Monday, October 21st, the start of a brand new week! Investors will see some heavy hitter earnings this week, including the first of the magnificent seven, Tesla reporting on Wednesday. The market is falling Monday, after hitting highs Thursday last week.
My name is Kevin Travers; here are the news stories and animal spirits hitting Wall Street Today.
$Spirit Airlines (SAVE.US)$ jumped more th...

34

26

1

Moomoo AI

Jan 22 06:02

Ms. Pai Panandiker's appointment, with her vast neuropsychiatry commercial expertise, is seen as invaluable for Neumora's potential commercialization of navacaprant and pipeline advancement. Her experience in neuroscience product commercialization is expected to boost Neumora's growth.

Press Release: Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

1

Moomoo AI

Dec 12, 2023 06:06

CEO of Neumora Therapeutics is optimistic over Mr. Duncan's appointment due to his legal expertise and program strategy, valuable to the company's goal of advancing neuroscience drug development. Duncan highlights Neumora's leading brain disorder pipeline and recent clinical progress.

Press Release: Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer

Moomoo AI

Oct 10, 2023 06:54

CEO of Neumora, Henry Gosebruch, values Dr. Lenz's successful trial experience and neuroscience expertise for their pipeline development. Dr. Lenz is excited to contribute significantly to Neumora's R&D and neuropsychiatry programs.

Press Release: Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development

NMRA Neumora Therapeutics

Trade Overview

Capital Trend

News

Comments